Hypoglycemics

The goal of a hypoglycemic is to lower the concentration of glucose in the blood. The action of these drugs is inconsistent with the goal of the Marshall ProtocolA curative medical treatment for chronic inflammatory disease. Based on the Marshall Pathogenesis. (MP), namely to destroy the pathogenic bacteria causing glucose imbalance in the first place.

Hypoglycemics work, at least in part, by interfering with immune function. One study found that metformin artificially decreased concentrations of both interleukin 6 (IL-6), and tumor necrosis factor-alphaA cytokine critical for effective immune surveillance and is required for proper proliferation and function of immune cells. (TNF-alphaA cytokine critical for effective immune surveillance and is required for proper proliferation and function of immune cells.) in type 2 diabetic patients.¹⁾

Certain adverse effects are associated with use of hyplogycemics. For example, metformin is associated with lactic acidosis. ²⁾

• Avandamet (contains rosiglitazone)
• exenatide (Byetta)
• nateglinide (Starlix)
• pioglitazone (Actos)
• metformin (Diabex, Glucophage, Glumetza, Ratio-Metformin)
• rosiglitazone (Avandia)